Atai Life Sciences PE Ratio 2020-2025 | ATAI
Current and historical p/e ratio for Atai Life Sciences (ATAI) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Atai Life Sciences PE ratio as of July 18, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Atai Life Sciences PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-07-18 |
3.23 |
|
0.00 |
| 2025-03-31 |
1.36 |
$-0.91 |
0.00 |
| 2024-12-31 |
1.33 |
$-0.93 |
0.00 |
| 2024-09-30 |
1.16 |
$-0.81 |
0.00 |
| 2024-06-30 |
1.33 |
$-0.40 |
0.00 |
| 2024-03-31 |
1.97 |
$-0.25 |
0.00 |
| 2023-12-31 |
1.41 |
$-0.29 |
0.00 |
| 2023-09-30 |
1.29 |
$-0.45 |
0.00 |
| 2023-06-30 |
1.72 |
$-0.92 |
0.00 |
| 2023-03-31 |
1.81 |
$-0.95 |
0.00 |
| 2022-12-31 |
2.66 |
$-0.98 |
0.00 |
| 2022-09-30 |
3.31 |
$-1.33 |
0.00 |
| 2022-06-30 |
3.64 |
$-1.32 |
0.00 |
| 2022-03-31 |
5.09 |
$-1.45 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.647B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
